Home › NDC Lookup › RxCUI directory › RxCUI 1791597

60 ML ifosfamide 50 MG/ML Injection — RxCUI 1791597

RxNorm drug concept · Semantic clinical drug
RxCUI 1791597 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1791597
Official name60 ML ifosfamide 50 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asifosfamide 3 GM per 60 ML Injection; ifosfamide 3 GM in 60 ML Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)159 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ifosfamide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ifosfamide is a chemotherapy drug used to treat germ cell testicular cancer — specifically when at least two earlier treatment regimens haven't worked. It's always given as part of...
  • Mesna is a protective drug that is always given alongside ifosfamide. One of ifosfamide's byproducts, acrolein, can irritate and damage your bladder, causing a serious condition ca...
  • Why do I also have to take mesna, and what does it do?
  • The most urgent things to call your care team about are: fever or signs of infection (your white blood cell count can drop dangerously low), blood in your urine, or any sudden conf...
📖 Read our full Ifosfamide Injection guide →

🕸️ Concept Web — How 60 ML ifosfamide 50 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 60 ML ifosfamide 50 MG/ML Injection RxCUI 1791597

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ifosfamide 5657
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ifosfamide Injection 1791587
    • Ifosfamide Injectable Product 1156288
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ifosfamide 50 MG/ML 330459

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ifosfamide 50 MG/ML SCDC · 330459
  • Ifosfamide Injection SCDF · 1791587
  • Ifosfamide Injectable Product SCDG · 1156288

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 1791597 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9530-01 1 VIAL in 1 BOX (0143-9530-01) / 60 mL in 1 VIAL Ifosfamide Hikma Pharmaceuticals USA Inc. 2017-06-10
00143-9531-01 1 VIAL in 1 BOX (0143-9531-01) / 20 mL in 1 VIAL Ifosfamide Hikma Pharmaceuticals USA Inc. 2017-06-10
Observed labelers: Hikma Pharmaceuticals USA Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9208 Ifosfamide injection 2 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.